The influence of previous hormone therapy on PSA response in prostate cancer patients (PTS) failing first-line androgen ablation

被引：0
|
作者：
Rassweiler, J [1 ]
机构：
[1] STADTKRANKENHAUS HEILBRONN,HEILBRONN,GERMANY
来源：
EUROPEAN JOURNAL OF CANCER | 1997年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：114 / 114
页数：1
相关论文
共 50 条
  • [1] The impact of previous hormone therapy on psa response to liarozole in prostate cancer patients failing first-line androgen ablation
    Rassweiler, JJ
    JOURNAL OF UROLOGY, 1998, 159 (05): : 131 - 131
  • [2] First-line therapy for metastatic hormone-sensitive prostate cancer
    Rexer, Heidrun
    Feyerabend, Susan
    Graefen, Markus
    AKTUELLE UROLOGIE, 2023, 54 (03) : 186 - 188
  • [3] Nilutamide as second line hormone therapy for prostate cancer after androgen ablation fails
    Kassouf, W
    Tanguay, S
    Aprikian, AG
    JOURNAL OF UROLOGY, 2003, 169 (05): : 1742 - 1744
  • [4] Clinical course and response to first-line androgen deprivation therapy in patients with PSA-progression after radical prostatectomy
    Bianco, FJ
    Doran, ZA
    Kattan, MW
    Fearn, PA
    Eastham, JA
    Scardino, PT
    JOURNAL OF UROLOGY, 2004, 171 (04): : 116 - 116
  • [5] SURVIVAL OUTCOMES IN OCTOGENARIAN AND NONAGENARIAN PATIENTS TREATED WITH FIRST-LINE ANDROGEN DEPRIVATION THERAPY FOR LOCALIZED PROSTATE CANCER
    Dell'Oglio, Paolo
    Bishr, Mohamed
    Boehm, Katharina
    Trudeau, Vincent
    Larcher, Alessandro
    Tian, Zhe
    Saad, Fred
    Capitanio, Umberto
    Briganti, Alberto
    Graefen, Markus
    Montorsi, Francesco
    Karakiewicz, Pierre
    JOURNAL OF UROLOGY, 2016, 195 (04): : E656 - E656
  • [6] Oral Vinorelbine (V) as first-line chemotherapy (CT) in elderly patients (pts) with hormone-refractory prostate cancer (HRPC)
    Caristi, Nicola
    Maisano, Roberto
    Pollicino, Andrea
    Toscano, Giuseppe
    Spadaro, Pietro
    Adamo, Vincenzo
    Chiofalo, Giuseppe
    Mare, Marzia
    Mafodda, Antonio
    Picciotto, Maria
    ANNALS OF ONCOLOGY, 2004, 15 : 114 - 115
  • [7] AUO First-line Therapy for metastatic hormone-sensitive Prostate Cancer (mHSPC)
    Rexer, H.
    Feyerabend, S.
    Graefen, M.
    UROLOGIE, 2023, 62 (04): : 441 - 442
  • [8] Results of hormone therapy as first-line treatment for high-risk prostate cancer
    Mottet, Nicolas
    CURRENT OPINION IN UROLOGY, 2013, 23 (04) : 355 - 359
  • [9] Diethylstilbesterol: First-line hormonal therapy for prostate cancer?
    Pitts, WR
    UROLOGY, 1999, 53 (03) : 660 - 661
  • [10] A phase II trial of docetaxel and erlotinib as first-line therapy for elderly patients with androgen-independent prostate cancer
    Mitchell Gross
    Celestia Higano
    Allan Pantuck
    Olga Castellanos
    Erica Green
    Koo Nguyen
    David B Agus
    BMC Cancer, 7
12345